Is Human Dermal Fibroblast Induced Multipotent Cell Exosomes safe in cosmetics?
Human Dermal Fibroblast Induced Multipotent Cell Exosomes has a safety rating of "MODERATE" in our database. EU status: permitted. US status: permitted.
INCI: HUMAN DERMAL FIBROBLAST INDUCED MULTIPOTENT CELL EXOSOMES
Human Dermal Fibroblast Induced Multipotent Cell Exosomes (CAS Not established) is a cosmetic cosmetic ingredient functioning as Skin conditioning; nano-carrier for bioactive cargo. EU Regulation 1223/2009 status: permitted. Industrial safety data is also available in the chemical safety database.
View industrial chemical safety profile for CAS Not established →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Human Dermal Fibroblast Induced Multipotent Cell Exosomes.
Calculate MoS for your specific formulation with the MoS Calculator.
Expert safety assessment and concern-level summary for Human Dermal Fibroblast Induced Multipotent Cell Exosomes.
Human Dermal Fibroblast Induced Multipotent Cell Exosomes has a safety rating of "MODERATE" in our database. EU status: permitted. US status: permitted.
Human Dermal Fibroblast Induced Multipotent Cell Exosomes EU regulatory status: permitted. This is based on EU Regulation 1223/2009 and its amendments.
Human Dermal Fibroblast Induced Multipotent Cell Exosomes functions as: Skin conditioning; nano-carrier for bioactive cargo. It is classified as a cosmetic ingredient in our database. CAS number: Not established.
Check Human Dermal Fibroblast Induced Multipotent Cell Exosomes compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Human Dermal Fibroblast Induced Multipotent Cell Exosomes in your formulation.